Company intelligence / Profile preview
Nasus Pharma
- Ownership
- Public · NSRX
- Development stage
- Phase 2
Overview
Nasus Pharma is a clinical-stage biopharmaceutical company developing powder-based intranasal products using proprietary microsphere technology. Their approach enables rapid drug absorption—up to seven times higher than solution-based drugs within the first four minutes—making it suitable for life-threatening emergencies. Recent clinical results for their intranasal epinephrine product have been positive and were presented at a major scientific meeting in early 2025.
- Therapeutic areas
- OtherImmunologyInfectious Diseases
- Modalities
- Powder-based intranasal drug deliverySmall molecules (inferred from use of epinephrine and other acute drugs)
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →Financials
- Market cap
- $28.9M
- Total revenue
- $0
- Enterprise value
- $17.1M
Beyond the preview
Go deeper on Nasus Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nasus Pharma.